3 Canadian Stocks For A Worsening Coronavirus Pandemic

 | Mar 18, 2020 02:02AM ET

The Canadian stocks listed, which should hold up during the Coronavirus outbreak, include a packaging, mobility, and gold stock.

Equity markets around the globe have effectively entered bear market territory this week. Several indexes including the Dow Jones and S&P 500 in the United States as well as the iShares S&P TSX 60 Index ETF (TSX:XIU) in Canada have declined well over 25% from record highs.

Yes, global consumer demand will be subdued this year. Several major industries including retail, airlines, energy and consumer technology will be negatively impacted as companies will lower earnings and revenue forecasts for 2020.

Further, the ongoing oil war between Saudi Arabia and Russia has resulted in rock-bottom crude prices, which has contributed heavily to the bear market.

While the short-term volatility will continue to impact equity investors, this decline needs to be viewed as an opportunity to buy companies with strong fundamentals. As Warren Buffett famously stated, “Be Fearful When Others Are Greedy and Greedy When Others Are Fearful.”

Here we look at three Canadian stocks that should be on the radar of contrarian and value investors.

h2 1. Cascades /h2

Cascades (TSX:CAS) is a paper and packaging company that produces, converts and sells packaging and tissue products composed primarily of recycled fibers. The Company operates through four segments: Containerboard, Boxboard Europe, Specialty Products (which constitutes the Company’s packaging Products) and Tissue Papers.

As the world is preparing for the worst in terms of the COVID-19 pandemic, there is a huge surge in demand for tissue papers, hand sanitizers and canned goods. This is where Cascades stands to benefit hugely.

Several grocery stores around the world are reporting a shortage in the supply of tissue papers and some are even having a strict limit on the number of products that can be bought by a single customer.

Tissue paper sales account for 30% of total revenue for Cascades and this has helped the Company outperform the broader indexes. Cascades stock is trading at $10.17, which is 24% below its 52-week high of $13.44 and is still up a stellar 33% in the last 12-month period, compared to the S&P 500 return of -2.5%.

While most companies may report lower-than-expected revenue, Cascades is all set to benefit from growing demand for its product line. In terms of valuation, Cascades is also one of the cheaper stocks to own on the TSX.

It has a price-to-sales ratio of 0.2 and an enterprise-value-to-sales ratio of 0.56. The stock is trading at a forward price-to-earnings multiple of 8.9 and has an estimated 5-year PEG ratio of just 0.28. With a dividend yield of 2.84%, Cascades is a tempting pick for value investors as it has significant upside potential.